arrow
M

Maria Kislova

botkin hospital
H指数:5
被引数:240

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of venetoclax‐based therapies on CLL‐associated autoimmune cytopenias: A retrospective study conducted by ERIC

维奈克拉为基础疗法对CLL相关自身免疫性血细胞减少症的影响:ERIC开展的一项回顾性研究

2026-11-060
OAAI
Minimal residual disease–guided ibrutinib and venetoclax in patients with chronic lymphocytic leukaemia and complex karyotype

微小残留病指导下的伊布替尼和维奈克拉在伴有复杂核型的慢性淋巴细胞白血病患者中的应用

2026-09-050
OAAI
Allogeneic Stem Cell Transplantation—A Salvage Option for High-Risk Chronic Lymphocytic Leukemia Patients: A 15-Year Single-Center Experience

异基因干细胞移植——高风险慢性淋巴细胞白血病患者的一种挽救性选择:一项15年单中心经验

2026-08-200
PRE
Central Nervous System Involvement in CLL: An International Retrospective Study by ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病中中枢神经系统受累:ERIC(欧洲慢性淋巴细胞白血病研究倡议)国际回顾性研究

2025-10-280
OAAI
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病患者的治疗策略和治疗顺序: 欧洲CLL研究计划ERIC的国际研究

2024-09-170
OAAI
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

CLL历史上的其他恶性肿瘤: ERIC进行的一项国际多中心研究,欧洲CLL研究倡议,和谐

2023-11-016
OAAI
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias
LEUKEMIA
IF13.4
2023-05-182
OAAI
Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection
2020-10-0943
OAAI